Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics

British Journal of Cancer

Volumn 81, Issue 7, 1999, Pages 1165-1173

  Engel, H ^a   Kleespies, C ^b   Friedrich, J ^b   Breidenbach, M ^b   Kallenborn, A ^b   Schondorf T ^b   Kolhagen, H ^b   Mallmann, P ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Circulating tumour cells; FISH; MACS

Indexed keywords

ANTIBODY; CYTOKERATIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CELL SELECTION; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 7; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DEVICE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; METASTASIS; MINIMAL RESIDUAL DISEASE; NUMERICAL CHROMOSOME ABERRATION; OVARY CANCER; PRIORITY JOURNAL; TUMOR CELL;

EID: 0032713917     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690825     Document Type: Article

References (54)

1. An HX, Niederacher D, Beckmann MW, Gohring UJ, Scharl A, Picard F, van Roeyen C, Schnurch HG and Bender HG (1995) ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int J Cancer 64: 291-297
2. Berois N, Varangot M, Osinaga E, Babino A, Caignault L, Muse I and Roseto A (1997) Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res 17: 2639-2646
3. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R and Hoon DS (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-2640
4. Cajulis RS, Kotliar S, Haines GK, Frias Hidvegi D and O'Gorman M (1994) Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diagn Cytopathol 11: 151-158
5. Dalta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475-482
6. Deville P, Theirry RF, Kievitis T, Kolluri R, Hopman AHN, Willard HF, Pearson PL and Cornelisse CJ (1988) Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res 48: 5825-5830
7. Cote RJ, Rosen PP, Lesser ML, Old LJ and Osborne MP (1991) Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749-1756
8. Cote RJ, Beattie EJ, Chaiwun B, Shi SR, Harvey J, Chen SC, Sherrod AE, Groshen S and Taylor CR (1995) Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 4: 415-423
9. Cote RJ, Houchens DP, Hitchcock CL, Saad AD, Nines RG, Greenson JK, schneebaum S, Arnold MW and Martin EW Jr (1996) Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabeled monoclonal antibody CC49. Cancer 77: 613-620
10. Diel IJ, Kaufmann M, Costa SD, Holle R, von Minckwitz G, Solomayer EF, Kaul S and Basetert G (1996) Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. J Natl Cancer Inst 88: 1652-1658
11. Dutrillaux B, Gerbault-Seureau M and Zafrani B (1990) Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paraploid cases with few chromosome changes. Cancer Genet Cytogenet 49: 203-217
12. Eaton MC, Hardingham JE, Kotasek D and Dobrovik A (1997) Immunobead RT-PCR: a sensitive detection method for detection of circulating tumor cells. Biotechniques 22: 100-105
13. Engel H, Friedrich J, Kleespies C, Kurbacher CM, Schöndorf T, Grecu O, Kolhagen H and Mallmann P (1998) Detection of chromosomal aberrations in tumor cells and tumor infiltrating lymphocytes by molecular cytogenetics in patients with gynecological cancer. Cancer Genet Cytogenet 106: 159-165
14. Fernandez JL, Goyanes V, Lopez-Fernandez C, Buno I and Gosalvez J (1996) Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis. Cancer Genet Cytogenet 86: 18-21
15. Fiegl M, Tueni C, Schenk T, Jakesz R, Gnat M, Reiner A, Rudas M, Pire-Danoewinata H, Marosi C and Huber H (1995) Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer 72: 51-55
16. Franklin WA, Shpall EJ, Archer P, Johnston CS, Garza-Williams S, Hami L, Bitter MA, Bast RC and Jones RB (1996) Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat 41: 1-13
17. Geleick D, Müller H, Matter A, Torhorst J and Regenass U (1990) Cytogenetics of breast cancer. Cancer Genet Cytogenet 46: 217-229
18. Harbeck N, Schwarze S, Schüren E, Yamamoto N, Moniwa N, Schmitt M, Dettmar P, Nathrath W, Jänicke F, Höfler H and Graeff H (1995) Model system for isolation of competent ovarian carcinoma cells from fresh tumor tissue by magnetic cell separation technique (MACS). Internat J Oncol 6: 1249-1254
19. Hardingham JE, Kotasek D, Farmer B, Butler RN, Mi JX, Sage RE and Dobrovic A (1993) Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 53: 3455-3458
20. Hardingham JE, Kotasek D, Sage RE, Eaton MC, Pascoe VH and Dobrovic A (1995) Detection of circulating tumor cells in colorectal cancer by immunobead_PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1: 789-794
21. Helfrich W, ten Poele R, Meersma GJ, Mulder NH, de Vries EJ, de Leij L and Smit EF (1997) A quantitative reverse transcriptase polymerase chain reaction based assay to detect carcinoma cells in peripheral blood. Br J Cancer 76: 29-35
22. Hildebrandt M, Mapara MY, Korner IJ, Bargou RC, Moldenhauer G and Dorken B (1997) Reverse transcriptase-polymerase chain reaction (RT PCR) controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol 25: 57-65
23. Ichikawa D, Hashimoto N, Hoshima M, Yamaguchi T, Sawai K, Nakumura Y, Takahashi T, Abe T and Inazawa J (1996) Analysis of numerical aberrations of specific chromosomes by fluorescence in situ hybridization as a diagnostic tool in breast cancer. Cancer 77: 2064-2069
24. Ishikawa T, Kobayashi M, Mai M, Suzuki T and Ooi A (1997) Amplification of the c-erbB 2 (Her-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridization. Am J Pathol 151: 761-768
25. Kallioniemi OP, Kallioniemi A, Kursiu W, Thor A, Chen LC, Smith HS, Waldman FM, Pinkel D and Gray JW (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89: 5321-5325
26. Kiechle-Schwarz M, Decker HJH, Berger CS, Fiebig CS and Sandberg AA (1991) Detection of monosomy in interphase nuclei and identification of marker chromosomes using biotinylated alpha-satellite DNA probes. Cancer Genet Cytogenet 51: 23-33
27. Kruger W, Krzizanowski C, Holweg M, Stockschlader M, Kroger N, Jung R, Mross K, Jonat W and Zander AR (1996) Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122: 679-686
28. Kruger WH, Stockschlader M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Loliger C, Gieseking F, Jonat W and Zander AR (1996) Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Bone Marrow Transplant 18: 18-20
29. Kvalheim G (1996) Detection of occult tumour cells in bone marrow and blood in breast cancer patients methods and clinical significance. Acta Oncol 35: 13-18
30. Le Beau MM (1993) Detecting genetic changes in human tumor cells: Have scientists 'gone fishing?' Blood 81: 1979-1983
31. Luppi M, Morselli M, Bandieri E, Federico M, Marasca R, Barozzi P, Ferrari MG, Savarino M, Frassoldati A and Torelli G (1996) Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7: 619-624
32. Mapara MY, Körner IJ, Hildebrandt M, Bargon R, Krahl D, Reichardt P and Dörken B (1997) Monitoring of tumor cell purging after highly enriched efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 89: 337-344
33. Martin VM, Siewert C, Scharl A, Harms T, Heinze R, Ohl S, Radbruch A, Miltenyi S and Schmitz J (1998) Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 26: 252-264
34. Micale MA, Visseher DW, Gulino SE and Wolman SR (1994) Chromosomal aneuploidy in proliferative breast disease. Human Pathol 25: 29-35
35. Miltenyi S, Muller W, Weichel W and Radbruch A (1990) High gradient magnetic cell separation with MACS. Cytometry 11: 231-238
36. Moscinski LC, Trudeau WL, Fields KK and Elfenbein GJ (1996) High-sensitive detection of minimal residual breast carcinoma using polymerase chain reaction and primers for cytokeratin 19. Diagn Mol Pathol 5: 173-180
37. Muller P, Weckermann D, Riethmuller G and Schlimok G (1996) Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet 88: 8-16
38. Naume B, Borgen E, Beiske K, Herstad TK, Ravnas G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S and Kvalheim G (1997) Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 6: 103-114
39. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S and Koyama H (1996) Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification. Am J Pathol 148: 649-656
40. Pantel K (1996) Detection of minimal residual disease in patients with solid tumors. J Hematother 5: 359-367
41. Persons DL, Hartmann LC, Herath JF, Keeney GL and Jenkins RB (1994) Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102: 775-779
42. Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar AK, Slamon DJ, Phillips RN, Ross JS, Wolman SR and Flom KJ (1997) HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol 15: 2894-2904
43. Revillion F, Bonneterre J and Peyrat JP (1998) ERBB2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34: 791-808
44. Ross AA (1998) Minimal residual disease in solid tumor malignancies: a review. J Hematother 7: 9-18
45. Sauter G, Feichter G, Torhorst J, Moch H, Novotna H, Wagner U, Durmuller U and Waldman FM (1996) Flourescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies. Acta Cytol 40: 164-173
46. Schildkraut JM, Collins NK, Dent GA, Tucker JA, Barret JC, Berchuck A and Boyd J (1995) Loss of heterozygosity on chromosome 17q11 21 in cancers of women who have both breast and ovarian cancer. Am J Obstet Gynecol 172: 908-913
47. Schoenefeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnet HD and Coombes RC (1994) Detection of breast cancer micrometatases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-2990
48. Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y and Coombes RC (1997) The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854-861
49. Smith B, Selby R, Southgate J, Pittman K, Bradley C and Blair GE (1991) Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227-1229
50. Traystman MD, Cochran GT, Hake SJ, Kuszynski CA, Mann SL, Murphy BJ, Pirruccello SJ, Zuvanich E and Sharp JG (1997) Comparison of molecular cytokeratin 19 reverse transcriptase polymerase chain reaction (CK19 RT-PCR) and immunocytochemical detection of micrometastatic breast cancer cells in hematopoietic harvests. J Hematother 6: 551-561
51. Visscher DW, Wallis T and Ritchie CA (1995) Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis. Cytometry 21: 95-100
52. Visscher DW, Wallis TL and Crissmann JD (1996) Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 77: 315-320
53. Vrendenburgh JJ, Silva O, Tyer C, DeSombre K, Abou-Ghalia A, Cook M, Layfied L, Peters WP and Bast RC Jr (1996) A comparison of immunohistochemistry, two-color immunofluorescence, and flow cytometry with cell sorting for the detection of micrometastatic breast cancer in the bone marrow. J Hematother 5: 57-62
54. Xu J and Wang N (1994) Identification of chromosomal structural alterations in human ovarian carcinoma cells using combined GTG-banding and repetitive fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 74: 1-7